Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson’s disease

Background Transcranial magnetic stimulation (TMS) studies have found abnormalities in several excitatory and inhibitory circuits in the motor cortex in PD. These include motor evoked potential (MEP) recruitment curve, silent period duration (SP), short-interval intracortical inhibition (SICI), intracortical facilitation (ICF), and long-interval intracortical inhibition (LICI). Methods The authors studied the effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on these circuits in 12 patients with PD treated with STN DBS. Data from nine patients who completed the study were analyzed. Patients remained on their usual medications. The stimulators were set at the optimal parameters (ON), half the optimal amplitude (HALF), and switched off (OFF) in random order. Results The Unified PD Rating Scale motor scores were significantly lower in the ON compared to the HALF and OFF conditions. Resting SICI, studied with paired-pulse TMS at interstimulus interval of 2 ms, was reduced in the OFF and HALF conditions compared to normal subjects. STN stimulation restored SICI to normal levels. STN stimulation had no effect on motor threshold, MEP recruitment curve, SP, active SICI, ICF, and LICI. Conclusions Although restoration of short-interval intracortical inhibition by STN stimulation is similar to the effects of dopaminergic drugs, it has no effect on silent period duration and long-interval intracortical inhibition, which are also influenced by dopaminergic drugs. A previous study found that internal globus pallidus (GPi) stimulation reduced SP but did not change SICI. Thus, GPi and STN stimulation may affect different circuits in the motor cortex.

[1]  H. Siebner,et al.  Abnormal associative plasticity of the human motor cortex in writer's cramp. , 2003, Brain : a journal of neurology.

[2]  Gregory F. Molnar,et al.  Short and long latency afferent inhibition in Parkinson's disease. , 2003, Brain : a journal of neurology.

[3]  G. Johannsson,et al.  Growth Hormone Deficiency: Strategies and Indications to Continue Growth Hormone Therapy in Transition from Adolescence to Adult Life , 2003, Hormone Research in Paediatrics.

[4]  Paul Greengard,et al.  Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia , 2003, Nature Neuroscience.

[5]  C H Lücking,et al.  Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease. , 2003, Brain : a journal of neurology.

[6]  P. Brown Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[7]  J. Villemure,et al.  How do parkinsonian signs return after discontinuation of subthalamic DBS? , 2003, Neurology.

[8]  A. Benabid,et al.  Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation. , 2002, Brain : a journal of neurology.

[9]  D. Durstewitz,et al.  Bidirectional Dopamine Modulation of GABAergic Inhibition in Prefrontal Cortical Pyramidal Neurons , 2001, The Journal of Neuroscience.

[10]  M. Muenter,et al.  Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature , 2001, Movement disorders : official journal of the Movement Disorder Society.

[11]  A. Lang,et al.  Effects of internal globus pallidus stimulation on motor cortex excitability , 2001, Neurology.

[12]  P Ashby,et al.  Potentials recorded at the scalp by stimulation near the human subthalamic nucleus , 2001, Clinical Neurophysiology.

[13]  P. Perozzo,et al.  Deep brain stimulation of the subthalamic nucleus: Clinical effectiveness and safety , 2001, Neurology.

[14]  Robert Chen,et al.  Interactions between two different inhibitory systems in the human motor cortex , 2001, The Journal of physiology.

[15]  J. Obeso,et al.  Dorsal subthalamotomy for Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[16]  Christine Haberler,et al.  No tissue damage by chronic deep brain stimulation in Parkinson's disease , 2000, Annals of neurology.

[17]  M. Hallett,et al.  The relative metabolic demand of inhibition and excitation , 2000, Nature.

[18]  A. Lang,et al.  Surgery for Parkinson disease: A critical evaluation of the state of the art. , 2000, Archives of neurology.

[19]  A. Strafella,et al.  Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study , 2000, Clinical Neurophysiology.

[20]  L. Cohen,et al.  Induction of plasticity in the human motor cortex by paired associative stimulation. , 2000, Brain : a journal of neurology.

[21]  P. Calabresi,et al.  Unilateral dopamine denervation blocks corticostriatal LTP. , 1999, Journal of neurophysiology.

[22]  P. Ashby,et al.  Mechanism of the silent period following transcranial magnetic stimulation Evidence from epidural recordings , 1999, Experimental Brain Research.

[23]  P Ashby,et al.  Neurophysiological effects of stimulation through electrodes in the human subthalamic nucleus. , 1999, Brain : a journal of neurology.

[24]  R. J. Helscher,et al.  Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus , 1999, Journal of Neurology.

[25]  J C Rothwell,et al.  Releasing the brakes before pressing the gas pedal , 1999, Neurology.

[26]  P. Ashby,et al.  Inhibition in the human motor cortex is reduced just before a voluntary contraction , 1999, Neurology.

[27]  A. Lozano,et al.  Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation , 1999, Neurology.

[28]  B Conrad,et al.  A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. , 1999, Archives of neurology.

[29]  E. Moro,et al.  Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease , 1999, Neurology.

[30]  F. Jiménez-Jiménez,et al.  Subthalamic nucleus stimulation improves directly levodopa induced dyskinesias in Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[31]  M. Torricelli,et al.  Effects of Dexamethasone and Dexamethasone plus Naltrexone on Pituitary Response to GnRH and TRH in Normal Women , 1999, Hormone Research in Paediatrics.

[32]  P. Ashby,et al.  Safety of transcranial magnetic stimulation in patients with implanted deep brain stimulators , 1999, Movement disorders : official journal of the Movement Disorder Society.

[33]  V Sturm,et al.  Bilateral high‐frequency stimulation of the internal globus pallidus in advanced Parkinson's disease , 1998, Annals of neurology.

[34]  M Hallett,et al.  Dextromethorphan decreases the excitability of the human motor cortex , 1998, Neurology.

[35]  A. Benabid,et al.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.

[36]  R. J. Allan,et al.  Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease , 1998, Annals of neurology.

[37]  A. Lang,et al.  Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease , 1998, Neurology.

[38]  A L Benabid,et al.  Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. , 1998, Brain : a journal of neurology.

[39]  J. Rothwell,et al.  Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits , 1998, Experimental Brain Research.

[40]  Richard S. J. Frackowiak,et al.  Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease , 1997, Annals of neurology.

[41]  K. Lyons,et al.  High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease , 1997, Neurology.

[42]  A. Strafella,et al.  Motor evoked responses to paired cortical magnetic stimulation in Parkinson's disease. , 1997, Electroencephalography and clinical neurophysiology.

[43]  H. Tsuji,et al.  Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. , 1997, The Journal of physiology.

[44]  E. Hirsch,et al.  Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. , 1996, Brain : a journal of neurology.

[45]  Walter Paulus,et al.  Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation , 1996, Neuroscience Letters.

[46]  J. A. Obeso,et al.  Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study , 1996, Neuroscience.

[47]  A. Berardelli,et al.  Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. , 1996, Brain : a journal of neurology.

[48]  W Paulus,et al.  Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study. , 1995, Brain : a journal of neurology.

[49]  J. L. Taylor,et al.  The effect of voluntary contraction on cortico‐cortical inhibition in human motor cortex. , 1995, Journal of Physiology.

[50]  R. Inzelberg,et al.  Changes in excitability of motor cortical circuitry in patients with parkinson's disease , 1995, Annals of neurology.

[51]  H. Bergman,et al.  The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. , 1994, Journal of neurophysiology.

[52]  M. Hallett,et al.  Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson's disease , 1994, Neurology.

[53]  N Accornero,et al.  Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. , 1994, Brain : a journal of neurology.

[54]  C. Marsden,et al.  Corticocortical inhibition in human motor cortex. , 1993, The Journal of physiology.

[55]  M. Hallett,et al.  Human motor evoked responses to paired transcranial magnetic stimuli. , 1992, Electroencephalography and clinical neurophysiology.

[56]  Richard S. J. Frackowiak,et al.  Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study , 1992, Annals of neurology.

[57]  R. Watts,et al.  The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism. , 1992, Neurologic clinics.

[58]  B. Berger,et al.  Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease , 1991, Annals of neurology.

[59]  R. Mutani,et al.  Parkinson's disease rigidity , 1991, Neurology.

[60]  M. Hallett,et al.  Spinal motor neuron excitability during the silent period after cortical stimulation. , 1991, Electroencephalography and clinical neurophysiology.

[61]  B. Berger,et al.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates , 1991, Trends in Neurosciences.

[62]  H. Bergman,et al.  Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.

[63]  M. Delong,et al.  Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.

[64]  J. Obeso,et al.  Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. , 2000, Neurology.

[65]  M. Hallett,et al.  Reorganization in motor cortex in amputees and in normal volunteers after ischemic limb deafferentation. , 1999, Electroencephalography and clinical neurophysiology. Supplement.

[66]  A. Lang,et al.  Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. , 1998, Movement disorders : official journal of the Movement Disorder Society.

[67]  T. Aziz,et al.  Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate , 1991, Movement disorders : official journal of the Movement Disorder Society.

[68]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.